Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 37,090 | N/A | N/A |
| Receivables | 500 | N/A | N/A |
| TOTAL | $37,731 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 64 | N/A | N/A |
| Other Non-Current Assets | 627 | 0 | 0 |
| TOTAL | $692 | $N/A | $N/A |
| Total Assets | $38,423 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,481 | 0 | 0 |
| Accrued Expenses | 699 | N/A | N/A |
| TOTAL | $2,256 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 58,649 | 0 | 0 |
| TOTAL | $58,649 | $N/A | $N/A |
| Total Liabilities | $60,905 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 5 | N/A | N/A |
| Retained earnings | -25,738 | N/A | N/A |
| TOTAL | $-22,482 | $N/A | $N/A |
| Total Liabilities And Equity | $38,423 | $0 | $0 |